[Bronchiolitis. We know what is the reason and how to treat]

Grzegorz Lis1

  • 1Oddział Pulmonologii, Alergologii i Dermatologii. Klinika Chorób Dzieci CM UJ, Kraków. milis@cyf-kr.edu.pl

Przeglad Lekarski
|May 14, 2011
PubMed

Insights

Bronchiolitis, a common infant respiratory illness, is often caused by viruses like RSV. Nebulized hypertonic saline shows promise in improving outcomes for this condition.

Area of Science:

  • Pediatrics
  • Respiratory Medicine
  • Infectious Diseases

Context:

  • Bronchiolitis is a frequent respiratory illness in infants and young children.
  • Diagnosis is primarily clinical, with lab tests assessing severity.
  • Viral infections, notably RSV and rhinovirus, are the primary cause.

Purpose:

  • To review current treatment controversies and emerging therapies for bronchiolitis.
  • To evaluate the efficacy and safety of nebulized hypertonic saline.
  • To inform clinical practice regarding bronchiolitis management.

Summary:

  • Inflammation in bronchiolitis involves edema, epithelial necrosis, mucus production, and potential bronchospasm.
  • Established treatments like bronchodilators, steroids, and antivirals lack proven efficacy.
  • Nebulized hypertonic saline demonstrates potential to alter the disease course favorably.

Impact:

  • Nebulized hypertonic saline offers a potentially effective and safe treatment option.
  • This approach may lead to routine acceptance in pediatric bronchiolitis care.
  • Improved management can enhance patient outcomes and reduce healthcare burdens.

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...